Geode Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.44M | Buy |
|
|||||
|
2022
Q3 | $2.74M | Buy |
|
|||||
|
2022
Q2 | $1.03M | Sell |
|
|||||
|
2022
Q1 | $853K | Sell |
|
|||||
|
2021
Q4 | $810K | Sell |
|
|||||
|
2021
Q3 | $1.12M | Buy |
|
|||||
|
2021
Q2 | $1.35M | Sell |
|
|||||
|
2021
Q1 | $2.69M | Buy |
|
|||||
|
2020
Q4 | $4.82M | Buy |
|
|||||
|
2020
Q3 | $3.59M | Buy |
|
|||||
|
2020
Q2 | $3.55M | Buy |
|
|||||
|
2020
Q1 | $2.98M | Buy |
|
|||||
|
2019
Q4 | $2.43M | Buy |
|
|||||
|
2019
Q3 | $1.45M | Buy |
|
|||||
|
2019
Q2 | $2.94M | Buy |
|
|||||
|
2019
Q1 | $2.74M | Buy |
|
|||||
|
2018
Q4 | $2.6M | Sell |
|
|||||
|
2018
Q3 | $3.37M | Buy |
|
|||||
|
2018
Q2 | $3.41M | Buy |
|
|||||
|
2018
Q1 | $4.21M | Buy |
|
|||||
|
2017
Q4 | $4.33M | Buy |
|
|||||
|
2017
Q3 | $1.93M | Buy |
|
|||||
|
2017
Q2 | $1.79M | Sell |
|
|||||
|
2017
Q1 | $2.44M | Buy |
|
|||||
|
2016
Q4 | $1.46M | Sell |
|
|||||
|
2016
Q3 | $1.5M | Buy |
|
|||||
|
2016
Q2 | $1.58M | Buy |
|
|||||
|
2016
Q1 | $1.92K | Buy |
|
|||||
|
2015
Q4 | $2.46M | Buy |
|
|||||
|
2015
Q3 | $2.39M | Buy |
|
|||||
|
2015
Q2 | $1.41M | Buy |
|
|||||
|
2015
Q1 | $1.26M | Buy |
|
|||||
|
2014
Q4 | $411K | Buy |
|
|||||
|
2014
Q3 | $329K | Buy |
|
|||||
|
2014
Q2 | $211K | Sell |
|
|||||
|
2014
Q1 | $325K | Buy |
|